Company Filing History:
1 out of 832,880 Years Active: 2005
Title: Innovations of Baiyong Li in Pharmaceutical Development
Introduction: Baiyong Li is an accomplished inventor based in Clinton, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the identification of compounds that can be used to treat various disease states.
Latest Patents: Baiyong Li holds a patent titled "Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2." This invention reveals that prostaglandin D2 (PGD2) is the natural ligand for the orphan receptor CRTH2. The interaction between these two is crucial for the development of valuable pharmaceuticals. The patent outlines methods for screening therapeutic compounds that are useful in treating PGD-related disorders such as allergies, asthma, and inflammation. Additionally, appropriate assay methodologies are disclosed in the patent.
Career Highlights: Throughout his career, Baiyong Li has focused on innovative approaches to drug discovery and development. His work has the potential to lead to significant advancements in the treatment of conditions that affect millions of people worldwide.
Collaborations: Baiyong Li has collaborated with notable professionals in his field, including Kuldeep S Neote and Ronald P Gladue. These collaborations have further enhanced the impact of his research and inventions.
Conclusion: Baiyong Li's contributions to pharmaceutical innovation, particularly through his patent on PGD2-related treatments, highlight his role as a key figure in the advancement of medical science. His work continues to pave the way for new therapeutic options for patients suffering from various disorders.